PPE had a recent institutional capital raise equivalent to 17% of the current market cap. At completion, the shares rose to close at a 45% premium to the raising price. With a retail captial raise (and further dilution) around the corner I would have thought prices would have stayed pretty flat or possibly fallen. They're still trading well above the issue price of $1.10 (currently $1.415).
I'm still fairly new to investing so the answer may be the most obvious one - Is the price premium to the capital raising price purely based on how highly the market views this company? I tend to think of shareholder dilution as a negative and was surprised by this result.
Thanks